Cargando…

An economic evaluation of anticipated costs and savings of a behavior change intervention to enhance medication adherence

Medication adherence across disease states is generally poor. Research has focused on various methods to improve medication adherence, but there is little conclusive evidence regarding specific methods efficacy. The Transtheoretical Model for Behavior Change has been used to modify existing addictiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiegand, Phillip N., Wertheimer, Albert I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141867/
https://www.ncbi.nlm.nih.gov/pubmed/25157283
_version_ 1782331708621717504
author Wiegand, Phillip N.
Wertheimer, Albert I.
author_facet Wiegand, Phillip N.
Wertheimer, Albert I.
author_sort Wiegand, Phillip N.
collection PubMed
description Medication adherence across disease states is generally poor. Research has focused on various methods to improve medication adherence, but there is little conclusive evidence regarding specific methods efficacy. The Transtheoretical Model for Behavior Change has been used to modify existing addictive behaviors but not in medication adherence specifically. As a behavioral component is inherently related to medication adherence, it is thought that this model may be applicable. OBJECTIVE: The purpose of this research is to evaluate the costs and savings of implementing a novel behavioral intervention against the cost of poor medication adherence to determine whether further development is realistic. METHODS: The basic tools required to administer this intervention were determined through primary literature review and priced by vendors supplying such materials. Diabetes Mellitus Type 2 (DM2) was used as a vehicle to establish the cost of care for long-term complications of a chronic disease. The primary literature provided information regarding the cost of care for DM2 morbidity and outpatient annual drug therapy expenditure. The total cost of the behavioral intervention components and the cost of care for DM2 morbidity were applied to a theoretical cohort of 1000 patients. By dividing this cost across 1000 patients, a per-patient cost was yielded and multiplied over a 16-year timeframe. RESULTS: It was found that the cost to implement the behavioral intervention and resultant medication costs is USD13,574 per-patient over 16 years. The cost to treat complications of diabetes mellitus is USD 36,528 per patient over the 16 years. The total amount of healthcare dollars potentially saved by utilizing this intervention is USD 22,954 per-patient. CONCLUSIONS: It appears that the cost to implement this behavioral intervention is reasonable and permits further evaluation in other chronic conditions with notoriously poor adherence levels.
format Online
Article
Text
id pubmed-4141867
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Centro de Investigaciones y Publicaciones Farmaceuticas
record_format MEDLINE/PubMed
spelling pubmed-41418672014-08-25 An economic evaluation of anticipated costs and savings of a behavior change intervention to enhance medication adherence Wiegand, Phillip N. Wertheimer, Albert I. Pharm Pract (Granada) Original Research Medication adherence across disease states is generally poor. Research has focused on various methods to improve medication adherence, but there is little conclusive evidence regarding specific methods efficacy. The Transtheoretical Model for Behavior Change has been used to modify existing addictive behaviors but not in medication adherence specifically. As a behavioral component is inherently related to medication adherence, it is thought that this model may be applicable. OBJECTIVE: The purpose of this research is to evaluate the costs and savings of implementing a novel behavioral intervention against the cost of poor medication adherence to determine whether further development is realistic. METHODS: The basic tools required to administer this intervention were determined through primary literature review and priced by vendors supplying such materials. Diabetes Mellitus Type 2 (DM2) was used as a vehicle to establish the cost of care for long-term complications of a chronic disease. The primary literature provided information regarding the cost of care for DM2 morbidity and outpatient annual drug therapy expenditure. The total cost of the behavioral intervention components and the cost of care for DM2 morbidity were applied to a theoretical cohort of 1000 patients. By dividing this cost across 1000 patients, a per-patient cost was yielded and multiplied over a 16-year timeframe. RESULTS: It was found that the cost to implement the behavioral intervention and resultant medication costs is USD13,574 per-patient over 16 years. The cost to treat complications of diabetes mellitus is USD 36,528 per patient over the 16 years. The total amount of healthcare dollars potentially saved by utilizing this intervention is USD 22,954 per-patient. CONCLUSIONS: It appears that the cost to implement this behavioral intervention is reasonable and permits further evaluation in other chronic conditions with notoriously poor adherence levels. Centro de Investigaciones y Publicaciones Farmaceuticas 2008 2008-06-17 /pmc/articles/PMC4141867/ /pubmed/25157283 Text en Copyright: © Pharmacy Practice http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Wiegand, Phillip N.
Wertheimer, Albert I.
An economic evaluation of anticipated costs and savings of a behavior change intervention to enhance medication adherence
title An economic evaluation of anticipated costs and savings of a behavior change intervention to enhance medication adherence
title_full An economic evaluation of anticipated costs and savings of a behavior change intervention to enhance medication adherence
title_fullStr An economic evaluation of anticipated costs and savings of a behavior change intervention to enhance medication adherence
title_full_unstemmed An economic evaluation of anticipated costs and savings of a behavior change intervention to enhance medication adherence
title_short An economic evaluation of anticipated costs and savings of a behavior change intervention to enhance medication adherence
title_sort economic evaluation of anticipated costs and savings of a behavior change intervention to enhance medication adherence
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141867/
https://www.ncbi.nlm.nih.gov/pubmed/25157283
work_keys_str_mv AT wiegandphillipn aneconomicevaluationofanticipatedcostsandsavingsofabehaviorchangeinterventiontoenhancemedicationadherence
AT wertheimeralberti aneconomicevaluationofanticipatedcostsandsavingsofabehaviorchangeinterventiontoenhancemedicationadherence
AT wiegandphillipn economicevaluationofanticipatedcostsandsavingsofabehaviorchangeinterventiontoenhancemedicationadherence
AT wertheimeralberti economicevaluationofanticipatedcostsandsavingsofabehaviorchangeinterventiontoenhancemedicationadherence